{
    "organizations": [],
    "uuid": "2718b5776a522f726411ee871b1f5b406e89ab63",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cereno-scientific-preliminary-anal/brief-cereno-scientific-preliminary-analysis-shows-cs1-was-safe-and-well-tolerated-idUSFWN1RV02G",
    "ord_in_thread": 0,
    "title": "BRIEF-Cereno Scientific: Preliminary Analysis Shows CS1 Was Safe And Well Tolerated",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - CERENO SCIENTIFIC AB:\n* FIRST CLINICAL STUDY WITH CS1 COMPLETED * PRELIMINARY ANALYSIS OF STUDY DATA SHOWS THAT CS1 WAS SAFE AND WELL TOLERATED. Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-18T14:35:00.000+03:00",
    "crawled": "2018-04-19T15:05:46.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "cereno",
        "scientific",
        "ab",
        "first",
        "clinical",
        "study",
        "cs1",
        "completed",
        "preliminary",
        "analysis",
        "study",
        "data",
        "show",
        "cs1",
        "safe",
        "well",
        "tolerated",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}